The United Arab Emirates is set to enhance its organ transplant program by incorporating advanced procedures involving the face, hands, arms, uterus, and intestine. This expansion is part of the next phase of the National Programme for Donation and Transplantation of Human Organs and Tissues, known as Hayat.

The Ministry of Health and Prevention (MoHAP) outlined that the Hayat program will broaden the scope of organs and tissues eligible for donation and transplantation. Among the new procedures planned are vascularised composite tissue transplants, which involve complex body parts such as the face, hands, and arms, alongside intestine and uterus transplants.

These developments mark a move into highly specialised transplant areas that require coordinated efforts from multiple medical teams before, during, and after surgery.

Expansion of Tissue Donation and New Donation Pathways

The program also intends to widen tissue donation to include corneas, bones, skin, and heart valves. Additionally, the initiative will develop donation after circulatory death (DCD), which involves organ donation after the permanent cessation of heart and blood circulation.

MoHAP stated that these expansions aim to increase the availability of organs and tissues for patients in need of life-saving or life-altering treatments, reinforcing the UAE's commitment to strengthening its organ donation framework.

Future of Transplants: Non-Human and Manufactured Organs

Looking ahead, the UAE is preparing for transplantation possibilities beyond human donors. The Ministry is advancing regulatory frameworks for non-human organs and tissues, including those derived from animals and those produced through 3D bioprinting, tissue engineering, and other cutting-edge technologies.

This initiative follows amendments to the UAE's organ transplant law, which now covers animal and manufactured organs. Under the updated law, the use of such organs is subject to licensing, clinical and laboratory testing for safety and efficacy, biological compatibility assessments, and requires written consent from the patient or their legal representative.

Plans also include establishing a national database to document details about non-human organs used in transplantation, encompassing their sources, biological composition, clinical trial outcomes, and safety data.

Details on Complex Transplants

Procedures such as hand and upper-limb transplants, already performed in other countries, are among the future priorities of the UAE’s program. These operations involve transplanting multiple tissue types—including bone, muscles, tendons, blood vessels, nerves, and skin—from deceased donors to replace missing or severely damaged limbs.

Patients undergo thorough medical and psychological evaluations before surgery, and compatibility tests are conducted to identify suitable donors. The surgical process involves reconnecting blood flow, movement, and sensory structures, often taking between eight and sixteen hours depending on the complexity.

Postoperative care includes hospital stays of two to four weeks, immunosuppressive medication to prevent rejection, and extensive rehabilitation to restore function and sensation.

Similarly, face transplants require the transplantation of various tissues such as skin, bone, muscles, blood vessels, nerves, and connective tissue. These procedures demand ongoing medical monitoring and immunosuppressive treatment to ensure tissue survival and functionality.

MoHAP has not yet detailed how these complex transplant surgeries will be implemented within the UAE but has identified them as key future objectives under the Hayat program.

Additional Organ Transplants

The program’s expansion also includes plans for uterus and intestine transplants. Alongside these, the extension of tissue donation and the development of donation after circulatory death are integral to the next stage of the Hayat initiative.